|
Volumn 99, Issue 17, 2002, Pages 11346-11350
|
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
a a a a a a a a a a |
Author keywords
Antibody engineering; Immunotherapy; Monoclonal antibody; Phage display; Vaccine
|
Indexed keywords
BOTULINUM TOXIN;
HYPERIMMUNE GLOBULIN;
MONOCLONAL ANTIBODY;
OLIGOCLONAL ANTIBODY;
RECOMBINANT ANTIBODY;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ANTIBODY ENGINEERING;
ANTIGEN BINDING;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG POTENCY;
FEMALE;
HUMORAL IMMUNITY;
IMMUNOTHERAPY;
LETHAL DOSE;
MALE;
MOUSE;
NONHUMAN;
PHAGE DISPLAY;
PRIORITY JOURNAL;
SEROTYPE;
ANIMALS;
ANTIBODIES, BACTERIAL;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
BASE SEQUENCE;
BOTULINUM TOXINS;
DNA PRIMERS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN HEAVY CHAINS;
KINETICS;
MALE;
MICE;
NEUTRALIZATION TESTS;
PHRENIC NERVE;
POLYMERASE CHAIN REACTION;
RECOMBINANT PROTEINS;
TIME FACTORS;
ANIMALIA;
|
EID: 0037143751
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.172229899 Document Type: Article |
Times cited : (302)
|
References (42)
|